Rating 3 years of From Harm to Hope

Rand Corp conducted a mixed-methods process evaluation of the 1st 3 years implementing the Treatment and Recovery Portfolio of the UK government’s 10-year drug strategy, From Harm to Hope. It claimed funding went into the treatment and recovery sector after an extended period of disinvestment, and the portfolio was largely implemented after delays.